OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes
Patrick P. Gleason, Benjamin Y. Urick, Landon Marshall, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 8, pp. 860-867
Open Access | Times Cited: 29
Patrick P. Gleason, Benjamin Y. Urick, Landon Marshall, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 8, pp. 860-867
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity
Patricia J. Rodriguez, Vincent Zhang, Samuel Gratzl, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2457349-e2457349
Open Access | Times Cited: 4
Patricia J. Rodriguez, Vincent Zhang, Samuel Gratzl, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2457349-e2457349
Open Access | Times Cited: 4
Estimating the lives that could be saved by expanded access to weight-loss drugs
Abhishek Pandey, Ye Yang, Chad R. Wells, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 8
Abhishek Pandey, Ye Yang, Chad R. Wells, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 8
The Impact of Contemporary Glucagon-like Peptide-1 Receptor Agonists on the Onset, Severity, and Conversion to Arthroplasty in Hip and Knee Osteoarthritis
Joshua R. Porto, Monish S. Lavu, Christian J. Hecht, et al.
Orthopaedic Journal of Sports Medicine (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Joshua R. Porto, Monish S. Lavu, Christian J. Hecht, et al.
Orthopaedic Journal of Sports Medicine (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Alternative dosing regimens of GLP ‐1 receptor agonists may reduce costs and maintain weight loss efficacy
Anıl Cengiz, Calvin Wu, Sean D. Lawley
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Anıl Cengiz, Calvin Wu, Sean D. Lawley
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Glucagon‐like peptide‐1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes
Gregory J. Grosicki, J. Graham Thomas, Nikhil V. Dhurandhar, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Gregory J. Grosicki, J. Graham Thomas, Nikhil V. Dhurandhar, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Trends, Demographics, and Outcomes for Glucagon-Like Peptide-1 Receptor Agonist Use in Total Knee Arthroplasty: An 11-Year Perspective
Jonathan Katzman, Muhammad Ammar Haider, Casey Cardillo, et al.
The Journal of Arthroplasty (2025)
Closed Access
Jonathan Katzman, Muhammad Ammar Haider, Casey Cardillo, et al.
The Journal of Arthroplasty (2025)
Closed Access
Real‐world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database
Emily R. Hankosky, Chanadda Chinthammit, Alexandra Meeks, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Emily R. Hankosky, Chanadda Chinthammit, Alexandra Meeks, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Real-World Use and Effectiveness of Tirzepatide Among People Without Evidence of Type 2 Diabetes in the United States
Emily R. Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Diabetes & Metabolism (2025), pp. 101636-101636
Open Access
Emily R. Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Diabetes & Metabolism (2025), pp. 101636-101636
Open Access
Real‐world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database
Theresa Hunter, Chanadda Chinthammit, Jennifer M. Ward, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Theresa Hunter, Chanadda Chinthammit, Jennifer M. Ward, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Treating class 2–3 obesity with glucagon‐like peptide‐1 agonists: A 2‐year real‐world cohort study
Mona Abdel‐Bary, Andrea Bródy, Jochen Schmitt, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Mona Abdel‐Bary, Andrea Bródy, Jochen Schmitt, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Older Adults’ Views on Insurance Coverage for Weight Management Medications
Lauren Oshman, Matthias Kirch, Erica Solway, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e252008-e252008
Open Access
Lauren Oshman, Matthias Kirch, Erica Solway, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e252008-e252008
Open Access
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study
Anders Boisen Jensen, Ubiratan Fabres Machado, Frida Renström, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access
Anders Boisen Jensen, Ubiratan Fabres Machado, Frida Renström, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐1RA ‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Sleeve Gastrectomy versus GLP-1 Agonist to Improve Kidney Transplant Access in End-Stage Renal Disease Patients with Obesity: A Decision Analysis
Marissa Di Napoli, Armaun D. Rouhi, Kristoffel R. Dumon, et al.
Surgery for Obesity and Related Diseases (2025)
Closed Access
Marissa Di Napoli, Armaun D. Rouhi, Kristoffel R. Dumon, et al.
Surgery for Obesity and Related Diseases (2025)
Closed Access
Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?
Siehoon Lah, Samantha Hocking
Internal Medicine Journal (2025)
Closed Access
Siehoon Lah, Samantha Hocking
Internal Medicine Journal (2025)
Closed Access
GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity
Margaret A. Stefater‐Richards, Grace Jhe, Yanjia J. Zhang
PEDIATRICS (2025)
Closed Access
Margaret A. Stefater‐Richards, Grace Jhe, Yanjia J. Zhang
PEDIATRICS (2025)
Closed Access
Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention
Alexander Chaitoff, Liam Bendicksen, William B. Feldman, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 10, pp. 1440-1442
Closed Access | Times Cited: 3
Alexander Chaitoff, Liam Bendicksen, William B. Feldman, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 10, pp. 1440-1442
Closed Access | Times Cited: 3
Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity
Patricia J Rodriguez, Vincent Zhang, Samuel Gratzl, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Patricia J Rodriguez, Vincent Zhang, Samuel Gratzl, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The Modification of Dietary Protein with Ammonium Hydroxide Enhancement Improves Longevity and Metabolic Outcomes in a Sex-Dependent Manner
Benjamin Barr, Lauren Gollahon
Nutrients (2024) Vol. 16, Iss. 16, pp. 2787-2787
Open Access | Times Cited: 2
Benjamin Barr, Lauren Gollahon
Nutrients (2024) Vol. 16, Iss. 16, pp. 2787-2787
Open Access | Times Cited: 2
A False Dichotomy: Rethinking the Debate Around Pharmacotherapy vs Bariatric Metabolic Surgery in Obesity Treatment
Larne Jones-Whiting, Mohammed Aradaib, Kamal Mahawar
Obesity Surgery (2024) Vol. 34, Iss. 11, pp. 3939-3940
Open Access | Times Cited: 2
Larne Jones-Whiting, Mohammed Aradaib, Kamal Mahawar
Obesity Surgery (2024) Vol. 34, Iss. 11, pp. 3939-3940
Open Access | Times Cited: 2
Your Weight and Your Wallet
Avery Brown, Karan R. Chhabra
Annals of Surgery (2024) Vol. 281, Iss. 2, pp. 201-203
Closed Access | Times Cited: 2
Avery Brown, Karan R. Chhabra
Annals of Surgery (2024) Vol. 281, Iss. 2, pp. 201-203
Closed Access | Times Cited: 2
Estimating the lives that could be saved by expanded access to weight-loss drugs
Abhishek Pandey, Ye Yang, Chad R. Wells, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Abhishek Pandey, Ye Yang, Chad R. Wells, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches
Johan Dellgren, Govind Persad, Ezekiel J. Emanuel
The Lancet (2024) Vol. 404, Iss. 10455, pp. 902-906
Closed Access | Times Cited: 1
Johan Dellgren, Govind Persad, Ezekiel J. Emanuel
The Lancet (2024) Vol. 404, Iss. 10455, pp. 902-906
Closed Access | Times Cited: 1
Injecting care and negotiating pleasures with weight loss pharmaceuticals
Megan Warin, Andrea E. Bombak, Babu George
Thesis Eleven (2024) Vol. 183, Iss. 1, pp. 49-68
Open Access
Megan Warin, Andrea E. Bombak, Babu George
Thesis Eleven (2024) Vol. 183, Iss. 1, pp. 49-68
Open Access
